In contrast to TCZ-treated patients, in TNFi-treated RA patients ESR and CRP showed differences between not active and active patients (ESR: 12.0 [5.0–21.0] mm vs 22.5 [15.0–53.3] mm, P = 0.021, Fig. 1e. The gene discussed is ESR1; the disease is rheumatoid arthritis.